Concepts (141)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Multiple Sclerosis | 19 | 2024 | 3079 | 2.580 |
Why?
|
Norway | 10 | 2023 | 448 | 0.910 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 2 | 2020 | 518 | 0.890 |
Why?
|
Registries | 6 | 2023 | 8089 | 0.890 |
Why?
|
Epstein-Barr Virus Infections | 3 | 2024 | 570 | 0.870 |
Why?
|
Minerals | 1 | 2019 | 275 | 0.610 |
Why?
|
Cod Liver Oil | 1 | 2015 | 9 | 0.530 |
Why?
|
Cesarean Section | 1 | 2023 | 1365 | 0.510 |
Why?
|
Body Size | 1 | 2017 | 461 | 0.480 |
Why?
|
Multiple Sclerosis, Chronic Progressive | 1 | 2016 | 236 | 0.470 |
Why?
|
Sodium, Dietary | 1 | 2017 | 418 | 0.460 |
Why?
|
Physical Fitness | 1 | 2017 | 733 | 0.420 |
Why?
|
Premature Birth | 2 | 2021 | 1721 | 0.420 |
Why?
|
Uric Acid | 1 | 2018 | 766 | 0.420 |
Why?
|
Parkinson Disease | 3 | 2023 | 2775 | 0.410 |
Why?
|
Smoking | 4 | 2023 | 8987 | 0.380 |
Why?
|
Cholecalciferol | 1 | 2015 | 537 | 0.360 |
Why?
|
Menopause | 1 | 2018 | 1626 | 0.360 |
Why?
|
Neurofilament Proteins | 3 | 2022 | 318 | 0.360 |
Why?
|
Vitamin D | 3 | 2020 | 3223 | 0.340 |
Why?
|
Demyelinating Diseases | 2 | 2022 | 354 | 0.320 |
Why?
|
Herpesvirus 4, Human | 3 | 2024 | 1041 | 0.320 |
Why?
|
Sex Characteristics | 1 | 2018 | 2585 | 0.300 |
Why?
|
Exercise | 3 | 2021 | 5615 | 0.290 |
Why?
|
Amyotrophic Lateral Sclerosis | 3 | 2023 | 1414 | 0.280 |
Why?
|
Diet | 3 | 2019 | 7939 | 0.280 |
Why?
|
Cotinine | 3 | 2023 | 206 | 0.270 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2021 | 3658 | 0.270 |
Why?
|
Risk | 5 | 2019 | 9687 | 0.270 |
Why?
|
Infectious Mononucleosis | 2 | 2016 | 131 | 0.260 |
Why?
|
Body Mass Index | 3 | 2022 | 12720 | 0.240 |
Why?
|
Case-Control Studies | 11 | 2023 | 21746 | 0.220 |
Why?
|
Cognition | 1 | 2020 | 6770 | 0.210 |
Why?
|
Dietary Supplements | 1 | 2015 | 3297 | 0.210 |
Why?
|
Cohort Studies | 12 | 2023 | 40561 | 0.200 |
Why?
|
Preconception Care | 1 | 2021 | 134 | 0.180 |
Why?
|
Phosphorus, Dietary | 1 | 2019 | 20 | 0.170 |
Why?
|
Potassium, Dietary | 1 | 2019 | 96 | 0.170 |
Why?
|
Intuition | 1 | 2018 | 21 | 0.170 |
Why?
|
Infant, Small for Gestational Age | 1 | 2021 | 440 | 0.170 |
Why?
|
Adult Survivors of Child Abuse | 1 | 2022 | 260 | 0.160 |
Why?
|
Prospective Studies | 8 | 2023 | 53288 | 0.160 |
Why?
|
Time | 1 | 2020 | 542 | 0.160 |
Why?
|
Iron, Dietary | 1 | 2019 | 141 | 0.160 |
Why?
|
Young Adult | 10 | 2022 | 56430 | 0.160 |
Why?
|
Validation Studies as Topic | 1 | 2017 | 159 | 0.150 |
Why?
|
Female | 24 | 2023 | 380194 | 0.140 |
Why?
|
Infant Mortality | 1 | 2021 | 754 | 0.140 |
Why?
|
Gout Suppressants | 1 | 2018 | 166 | 0.140 |
Why?
|
Copper | 1 | 2019 | 366 | 0.140 |
Why?
|
Manganese | 1 | 2019 | 408 | 0.140 |
Why?
|
Birth Weight | 2 | 2021 | 2069 | 0.140 |
Why?
|
Calcium, Dietary | 1 | 2019 | 526 | 0.140 |
Why?
|
Humans | 34 | 2024 | 744343 | 0.140 |
Why?
|
Pregnancy | 6 | 2023 | 29144 | 0.140 |
Why?
|
Epidemiology | 1 | 2018 | 287 | 0.130 |
Why?
|
Gestational Age | 2 | 2021 | 3493 | 0.130 |
Why?
|
Science | 1 | 2018 | 241 | 0.130 |
Why?
|
Adult | 17 | 2023 | 214055 | 0.130 |
Why?
|
Adolescent | 9 | 2022 | 85781 | 0.130 |
Why?
|
Magnesium | 1 | 2019 | 813 | 0.130 |
Why?
|
Child of Impaired Parents | 1 | 2019 | 455 | 0.130 |
Why?
|
Middle Aged | 14 | 2023 | 213383 | 0.130 |
Why?
|
Antibodies, Viral | 3 | 2022 | 3176 | 0.130 |
Why?
|
Vaccines | 1 | 2023 | 822 | 0.120 |
Why?
|
Zinc | 1 | 2019 | 684 | 0.120 |
Why?
|
Adjuvants, Immunologic | 1 | 2020 | 1000 | 0.120 |
Why?
|
Early Diagnosis | 1 | 2020 | 1184 | 0.120 |
Why?
|
Risk Factors | 13 | 2022 | 72290 | 0.120 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2023 | 1344 | 0.120 |
Why?
|
Disability Evaluation | 1 | 2021 | 1827 | 0.110 |
Why?
|
Child Abuse | 1 | 2022 | 1030 | 0.110 |
Why?
|
Breast Feeding | 1 | 2021 | 1338 | 0.110 |
Why?
|
Infant, Newborn | 2 | 2023 | 25625 | 0.110 |
Why?
|
Databases, Factual | 2 | 2018 | 7729 | 0.100 |
Why?
|
Mothers | 2 | 2021 | 2165 | 0.100 |
Why?
|
Nurses | 2 | 2021 | 2461 | 0.100 |
Why?
|
Ritonavir | 1 | 2013 | 322 | 0.100 |
Why?
|
HIV Protease Inhibitors | 1 | 2013 | 430 | 0.090 |
Why?
|
Male | 17 | 2023 | 350118 | 0.090 |
Why?
|
Age Factors | 2 | 2018 | 18370 | 0.090 |
Why?
|
Follow-Up Studies | 3 | 2020 | 39050 | 0.080 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2023 | 3047 | 0.080 |
Why?
|
Longitudinal Studies | 2 | 2022 | 13989 | 0.080 |
Why?
|
Aged | 7 | 2021 | 163280 | 0.080 |
Why?
|
Mental Health | 1 | 2021 | 3019 | 0.070 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2021 | 3336 | 0.070 |
Why?
|
Social Class | 1 | 2015 | 1999 | 0.070 |
Why?
|
Cytomegalovirus | 2 | 2022 | 732 | 0.070 |
Why?
|
Double-Blind Method | 1 | 2020 | 12026 | 0.070 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2015 | 10943 | 0.070 |
Why?
|
Migraine Disorders | 1 | 2017 | 1620 | 0.070 |
Why?
|
Adrenal Cortex Hormones | 2 | 2023 | 1855 | 0.060 |
Why?
|
Military Personnel | 2 | 2023 | 1133 | 0.060 |
Why?
|
Incidence | 2 | 2019 | 20947 | 0.060 |
Why?
|
Proportional Hazards Models | 1 | 2017 | 12354 | 0.050 |
Why?
|
Infant | 2 | 2021 | 35136 | 0.050 |
Why?
|
Cholinergic Antagonists | 1 | 2023 | 165 | 0.050 |
Why?
|
Aging | 1 | 2021 | 8664 | 0.050 |
Why?
|
Fatty Acids, Omega-6 | 1 | 2023 | 227 | 0.050 |
Why?
|
Asthma | 1 | 2019 | 6011 | 0.050 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2023 | 546 | 0.040 |
Why?
|
Quality of Life | 1 | 2021 | 12804 | 0.040 |
Why?
|
Diabetes Mellitus | 1 | 2017 | 5751 | 0.040 |
Why?
|
Epstein-Barr Virus Nuclear Antigens | 1 | 2019 | 150 | 0.040 |
Why?
|
Maternal Age | 1 | 2021 | 802 | 0.040 |
Why?
|
Finland | 1 | 2019 | 602 | 0.040 |
Why?
|
Disease Progression | 2 | 2023 | 13284 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2018 | 57776 | 0.030 |
Why?
|
Diet Surveys | 1 | 2019 | 1173 | 0.030 |
Why?
|
Brazil | 1 | 2019 | 1270 | 0.030 |
Why?
|
Fatty Acids | 1 | 2023 | 1809 | 0.030 |
Why?
|
Age of Onset | 1 | 2022 | 3271 | 0.030 |
Why?
|
Italy | 1 | 2017 | 832 | 0.030 |
Why?
|
Food | 1 | 2019 | 771 | 0.030 |
Why?
|
Reference Values | 1 | 2021 | 4982 | 0.030 |
Why?
|
Sweden | 1 | 2017 | 1345 | 0.030 |
Why?
|
Nontherapeutic Human Experimentation | 1 | 2013 | 24 | 0.030 |
Why?
|
ROC Curve | 1 | 2021 | 3527 | 0.030 |
Why?
|
Logistic Models | 2 | 2020 | 13408 | 0.030 |
Why?
|
Cytochrome P-450 CYP3A | 1 | 2013 | 115 | 0.030 |
Why?
|
United States | 2 | 2018 | 69872 | 0.030 |
Why?
|
Women's Health | 1 | 2021 | 2034 | 0.030 |
Why?
|
Midazolam | 1 | 2013 | 270 | 0.020 |
Why?
|
Recurrence | 1 | 2022 | 8340 | 0.020 |
Why?
|
Europe | 1 | 2016 | 3339 | 0.020 |
Why?
|
Lipids | 1 | 2020 | 3305 | 0.020 |
Why?
|
Child | 3 | 2022 | 77709 | 0.020 |
Why?
|
Area Under Curve | 1 | 2013 | 1654 | 0.020 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2021 | 2408 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2019 | 4560 | 0.020 |
Why?
|
Pregnancy Complications | 1 | 2021 | 2861 | 0.020 |
Why?
|
Educational Status | 1 | 2015 | 2540 | 0.020 |
Why?
|
Prevalence | 1 | 2022 | 15226 | 0.020 |
Why?
|
Odds Ratio | 1 | 2016 | 9849 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2022 | 25043 | 0.010 |
Why?
|
Obesity | 1 | 2022 | 12745 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2021 | 11725 | 0.010 |
Why?
|
Risk Assessment | 1 | 2016 | 23338 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2022 | 35421 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2021 | 77449 | 0.010 |
Why?
|
Concepts
(141)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(17)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_